EndoTrainer A revolution in non invasive surgery training
Minimally invasive surgery (MIS), or ‘key-hole surgery’, has huge benefits for patients and the healthcare system alike. However, its adoption is not as wide spread as it should be and today´s complex procedures can lead to a set...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto EndoTrainer
Duración del proyecto: 6 meses
Fecha Inicio: 2018-05-07
Fecha Fin: 2018-11-30
Líder del proyecto
SURGITRAINER, SL
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Minimally invasive surgery (MIS), or ‘key-hole surgery’, has huge benefits for patients and the healthcare system alike. However, its adoption is not as wide spread as it should be and today´s complex procedures can lead to a set of surgery mistakes generating unforseen patient harm and complicaton. One of the main reasons for the restrain on this full-release of MIS benefit has been due to the traditional, limited practical training. Students are taught the practicalities in real operating theatres with previously qualified surgeons. The environment is very costly and provides limited time for repeat practice. There are real bottlenecks in the supply of new, fully-capable MIS specialist surgeons. At Surgitrainer, we have developed the world’s first MIS simulator combining a realistic physical simulation with a virtual one. Trainees can practice at low cost, whilst having their progress precisely monitored and evaluated multiple times prior to their first ‘real’ procedure. We aim to speed up the generation of qualified MIS surgeons and help to ensure that many more people obtain the vast benefits of these procedures. With our first product entering final accreditation phase, we are applying for phase1 SME Instrument in order to help fund our final trial phase, develop our cloud ‘trainee interaction’ platform and to fully analyse the feasibility of our business model and route to market. With a general medical shift to simulation tool training and a 2.6 B USD market predicted by 2022, we predict to drive sales of nearly 10.4M Euros by 2022.